SPC
MIRM icon

Sigma Planning Corp’s Mirum Pharmaceuticals MIRM Stock Holding History

Sigma Planning Corp’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,400
Closed -$249K – 1359
2025
Q3 		$249K Buy
+3,400
New +$216K 0.01% 1114

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sigma Planning Corp's MIRM Position: Q4 2025 in Review

Sigma Planning Corp sold out of Mirum Pharmaceuticals (MIRM) in Q4 2025, closing a stake of 3,400 shares — an estimated $249K sold.

Sigma Planning Corp first reported a position in MIRM in Q3 2025 and held it in 1 quarter. The position peaked at $249K in Q3 2025. 281 funds tracked by Wall St. Rank hold MIRM as of Q4 2025.

  • Sigma Planning Corp reported no remaining Mirum Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Sigma Planning Corp sold 3,400 Mirum Pharmaceuticals shares in Q4 2025, an estimated $249K.
  • Sigma Planning Corp first reported a position in Mirum Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • Sigma Planning Corp's Mirum Pharmaceuticals position peaked at $249K in Q3 2025.
  • 281 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2025.

Based on Sigma Planning Corp's 13F filing for Q4 2025, filed 30 Jan 2026.